Toxic Metals Exposure and APOE4 Gene Variant in Cognitive Decline Disorders.
A Gasmi1, A Menzel2, S Piscopo1
1Société Francophone de Nutrithérapie et de Nutrigénétique Appliquée, Villeurbanne, France.
Archives of Razi Institute
|July 27, 2022
Summary
Toxic metals and apolipoprotein E protein interactions are crucial in neurodegenerative disorders. Understanding these links may reveal new treatment strategies for cognitive decline.
Area of Science:
- Neuroscience
- Toxicology
- Genetics
Background:
- Neurodegenerative disorders impair cognitive functions.
- Protein misfolding, particularly apolipoprotein E, is linked to cognitive impairments.
- Environmental toxic metals contribute to neurological disorder development.
Purpose of the Study:
- To explore the interaction between toxic metals and apolipoprotein E in cognitive decline.
- To understand the role of apolipoprotein E gene in cognitive disease phenotypes.
- To investigate the molecular mechanisms linking metal exposure to cognitive decline risk.
Main Methods:
- Literature search on Google Scholar and PubMed.
- Inclusion of studies on metal exposure-apolipoprotein association in cognitive decline.
- Review of apolipoprotein E4 gene's role in cognitive disease and amyloid-beta accumulation.
Main Results:
- Heavy metals are significant neurotoxic agents.
- Toxic metals interact with genetic factors in disease etiology.
- The apolipoprotein E4 gene's role in amyloid-beta accumulation was discussed.
Conclusions:
- Understanding metal-apolipoprotein E interactions offers potential therapeutic insights.
- This study provides hypothetical findings on chronic toxic metal exposure's neurotoxic effects.
- Enhanced knowledge of molecular mechanisms can improve understanding of cognitive decline disorders.
More Related Videos
Related Concept Videos
01:28Human Genetics
701
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
701
01:26Alzheimer's Disease: Overview
663
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
663
01:22Alzheimer's Disease: Treatment
258
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
258
01:23Role of Neurotransmitters in Memory
934
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
934
02:23RNA Editing
9.1K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.1K
01:28Disorders of the Nervous Tissue
1.5K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.5K